Skip to main content
. 2022 May 12;70(4):501–517. doi: 10.1007/s12026-022-09284-x

Fig. 3.

Fig. 3

Predicted primary structure properties of the multi-epitope vaccine subunit. a Number of amino acid residues within the construct and b solubility of the constructed MEV candidate